Literature DB >> 15458899

Bacterial vaginosis and risk of pelvic inflammatory disease.

Roberta B Ness1, Sharon L Hillier, Kevin E Kip, David E Soper, Carol A Stamm, James A McGregor, Debra C Bass, Richard L Sweet, Peter Rice, Holly E Richter.   

Abstract

BACKGROUND: Bacterial vaginosis commonly is found in women with pelvic inflammatory disease (PID), but it is unclear whether bacterial vaginosis leads to incident PID.
METHODS: Women (n = 1,179) from 5 U.S. centers were evaluated for a median of 3 years. Every 6-12 months, vaginal swabs were obtained for gram stain and culture of microflora. A vaginal microflora gram stain score of 7-10 was categorized as bacterial vaginosis. Pelvic inflammatory disease was diagnosed by presence of either histologic endometritis or pelvic pain and tenderness plus one of the following: oral temperature greater than 38.3 degrees C; sedimentation rate greater than 15 mm/hour; white blood count greater than 10,000; or lower genital tract detection of leukorrhea, mucopus, or Neisseria gonorrhoeae or Chlamydia trachomatis.
RESULTS: After adjustment for relevant demographic and lifestyle factors, baseline bacterial vaginosis was not associated with the development of PID (adjusted hazard ratio 0.89, 95% confidence interval 0.55-1.45). Carriage of bacterial vaginosis in the previous 6 months before a diagnosis (adjusted risk ratio 1.31, 95% confidence interval 0.71-2.42) also was not significantly associated with PID. Similarly, neither absence of hydrogen peroxide-producing Lactobacillus nor high levels of Gardnerella vaginalis significantly increased the risk of PID. Dense growth of pigmented, anaerobic gram-negative rods in the 6 months before diagnosis did significantly increase a woman's risk of PID (P =.04). One subgroup of women, women with 2 or more recent sexual partners, demonstrated associations among bacterial vaginosis, Gardnerella vaginalis, anaerobic gram-negative rods, and PID.
CONCLUSION: In this cohort of high-risk women, after adjustment for confounding factors, we found no overall increased risk of developing incident PID among women with bacterial vaginosis. LEVEL OF EVIDENCE: II-2

Entities:  

Mesh:

Year:  2004        PMID: 15458899     DOI: 10.1097/01.AOG.0000139512.37582.17

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  32 in total

1.  Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.

Authors:  Richard L Sweet
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

2.  Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition.

Authors:  Theofano Orfanelli; Aswathi Jayaram; Georgios Doulaveris; Larry J Forney; William J Ledger; Steven S Witkin
Journal:  Reprod Sci       Date:  2013-09-10       Impact factor: 3.060

3.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

5.  Toll-like receptor variants and cervical Atopobium vaginae infection in women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Patricia A Totten; Sabina G Astete; Michael J Ferris; David H Martin; Roberta B Ness; Catherine L Haggerty
Journal:  Am J Reprod Immunol       Date:  2017-12-29       Impact factor: 3.886

6.  New concepts in the etiology of bacterial vaginosis.

Authors:  Jane R Schwebke
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

7.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Adamma Aghaizu; Helen Atherton; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  BMJ       Date:  2010-04-08

8.  Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.

Authors:  Abdallah A Abdelmaksoud; Vishal N Koparde; Nihar U Sheth; Myrna G Serrano; Abigail L Glascock; Jennifer M Fettweis; Jerome F Strauss; Gregory A Buck; Kimberly K Jefferson
Journal:  Microbiology       Date:  2016-01-08       Impact factor: 2.777

9.  Differences in vaginal microbiome in African American women versus women of European ancestry.

Authors:  Jennifer M Fettweis; J Paul Brooks; Myrna G Serrano; Nihar U Sheth; Philippe H Girerd; David J Edwards; Jerome F Strauss; Kimberly K Jefferson; Gregory A Buck
Journal:  Microbiology (Reading)       Date:  2014-07-29       Impact factor: 2.777

10.  Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Helen Atherton; Adamma Aghaizu; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  Trials       Date:  2008-12-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.